Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats - Concepedia

Concepedia

Publication | Closed Access

Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats

120

Citations

44

References

2017

Year

Azza I. Othman, Mamdouh R. El‐Sawi, Mohamed A. El‐Missiry, Mohammad H. Abukhalil

Biomedicine & Pharmacotherapy

InflammationMetabolic SyndromeLipid PeroxidationDiabetesPhysiologyPharmacologyEpigallocatechin-3-gallate ProtectsDiabetes MellitusDiabetic CardiomyopathyMedicineOxidative StressHealth Sciences

References

	Year	Citations

Page 1